Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

SPDR® S&P Biotech ETF (XBI)

Delayed Data
As of Jul 22
 +0.40 / +0.68%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.


1 month+11.33% 3 years+14.56%
3 months+2.49% 5 years+19.27%
1 year-33.19% Since inception+13.41%
Data through 07/23/2016

Quote Details

Previous close$58.90
Open day’s range58.60 – 59.68
Net asset value (NAV)59.29 (07/22/2016)
Daily volume4,262,362
Average volume (3 months)7,374,319
Data as of 3:59pm ET, 07/22/2016

Peer Comparisonvs. Health ETFs

Performance 5-yr return+19.27%+15.32%
Expense Gross exp ratio0.35%0.47%
Risk 5 year sharpe ratio0.700.99
Net assets$2.0B$1.1B
Average market cap$4.2B$35.5B
Average P/E--20.8
Dividend / Share--0.22%


XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...


Top 5 Sectors
Portfolio weighting
Healthcare 100.00%
Business service 0.00%
Consumer goods 0.00%
Consumer service 0.00%
Energy 0.00%
Top 10 Holdings
Portfolio weighting
IONS Ionis Pharmaceuticals Inc2.69%
ABBV AbbVie2.55%
ALKS Alkermes Plc2.55%
MDVN Medivation Inc2.53%
INCY Incyte Corp2.50%
GILD Gilead Sciences2.48%
AMGN Amgen2.47%
BIIB Biogen2.47%
XON Intrexon Corp2.45%

Partner Offers

Search for Jobs